Shopping Cart
Remove All
Your shopping cart is currently empty
Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | - | In Stock | |
| 5 mg | $589 | - | In Stock | |
| 10 mg | $959 | - | In Stock | |
| 25 mg | $1,420 | - | In Stock | |
| 50 mg | $1,920 | Backorder | Backorder |
| Description | Rosmantuzumab (OMP-131R10) is a humanized monoclonal antibody against R-spondin 3 (RSPO3). Rosmantuzumab has potential antitumor activity and can be used to study advanced relapsed refractory solid tumors. |
| In vivo | Rosmantuzumab (25 mg/kg; intraperitoneal injection; once a week; for 4 weeks) significantly protects animals from developing liver fibrosis[1]. Rosmantuzumab (25 mg/kg; intraperitoneal injection; once every two weeks; for 6 weeks) in a bleomycin-induced pulmonary fibrosis mouse model significantly inhibits skin thickness, collagen deposition, and the number of α-SMA-positive cells[1]. |
| Synonyms | OMP-131R10 |
| Molecular Weight | 150 kDa |
| Cas No. | 1684393-04-1 |
| Relative Density. | no data available |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.